Loading...
ACHV Achieve Life
No Data
News
Comment
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022
RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public compan
Achieve Life Sciences (ACHV) Receives a Buy from H.C. Wainwright
In a report released today, Vernon Bernardino from H.C. Wainwright reiterated a Buy rating on Achieve Life Sciences (ACHV – Research Report), with a price target of $24.00. The company's shares close
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Short Interest Update
Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Rating) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 426,700 shares, an increa
Achieve Life Sciences (ACHV) Received its Third Buy in a Row
After Oppenheimer and H.C. Wainwright gave Achieve Life Sciences (NASDAQ: ACHV) a Buy rating last month, the company received another Buy, this time from Maxim Group. Analyst Jason McCarthy initiated
ACHV: First Quarter 2022 Results
By John Vandermosten, CFANASDAQ:ACHVREAD THE FULL ACHV RESEARCH REPORTAchieve Life Sciences, Inc. (NASDAQ:ACHV) reported first quarter 2022 results in a press release and held a conference call after
Achieve Life Sciences stock price target cut to $35 from $50 at Ladenburg Thalmann
Achieve Life Sciences stock price target cut to $35 from $50 at Ladenburg Thalmann
Analysts Are Bullish on Top Healthcare Stocks: Cormedix (CRMD), Achieve Life Sciences (ACHV)
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cormedix (CRMD – Research Report) and Achieve Life Sciences (ACHV – Research Report) with bullish sentime
Achieve Life Sciences, Inc. CEO John Bencich on Q1 2022 Results -- Earnings Call Transcript >ACHV
From Seeking Alpha: Achieve Life Sciences, Inc. CEO John Bencich on Q1 2022 Results -- Earnings Call Transcript
Achieve Life Sciences: Q1 Earnings Insights
Achieve Life Sciences (NASDAQ:ACHV) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Achieve Life Sciences be
Achieve Life Sciences reports Q1 EPS (80c), consensus (81c)
As of March 31, 2022, the company's cash, cash equivalents, and restricted cash was $36.4 million. "Cytisinicline exceeded our expectations in the ORCA-2 trial by delivering impressive efficacy and to